Promentis Pharmaceuticals' Series B Round

Promentis Pharmaceuticals raised a round of funding on January 17, 2014.

Promentis Pharmaceuticals is a pharmaceutical company developing compounds for the treatment of schizophrenia and other central nervous system disorders. Promentis' drug development efforts are focuse…

Articles about Promentis Pharmaceuticals' Series B Round: